Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2009
Cargando información sobre las referencias
To evaluate the dose-response relationship of 5 dose of CP-690,550, compared to placebo for the treatment of signs and symptoms in patients with active RA who failed an adequate trial of therapy with at least 1 DMARD in a 12-week therapy.
Epistemonikos ID: 54e05e60d7a5d431fce18baeebfca4e313ee2abb
First added on: Jun 11, 2017